1970
DOI: 10.1111/j.1600-0447.1970.tb02105.x
|View full text |Cite
|
Sign up to set email alerts
|

THE KLEINE‐LEVIN SYNDROME Report of a case and discussion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1971
1971
2010
2010

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 12 publications
0
4
0
Order By: Relevance
“…The genetic diseases were heterogeneous and included a case of mosaicism with Robert's syndrome, phocomelia, mild mental retardation, optic atrophy, bilateral facial palsy (Hasegawa et al, 1998), a case with Prader-Willi syndrome (Gau et al, 1996), an unidentified disease with mental retardation and bilateral pyramidal syndrome (Livrea et al, 1977), another complex case of consanguinity, mental retardation, an ectodermal disorder (incontinentia pigmenti), acanthosis nigricans, and hereditary exostosis (Reimao and Shimizu, 1998) and developmental Asperger's disease in two patients, one with cortical dysplasia and retinitis pigmentosa (Berthier et al, 1992). As for the three patients with infectious encephalitis of unknown origin, one had an acute viral meningo-encephalitis and high CSF lymphocyte counts (Merriam, 1986) while another had a meningo-encephalitis with neurological sequels, including left hypo-sensitivity, central facial palsy, concentric loss of visual fields and bilateral facial spasms (Persson et al, 1969). KLS also occurred in a context of gastrointestinal symptoms in the 1930's in a woman with recurrent episodes of variable hypersomnia, sometimes severe insomnia, and diarrhoea lasting over a 30-year period (Wilder, 1972).…”
Section: Cases With Secondary Kls Causesmentioning
confidence: 99%
“…The genetic diseases were heterogeneous and included a case of mosaicism with Robert's syndrome, phocomelia, mild mental retardation, optic atrophy, bilateral facial palsy (Hasegawa et al, 1998), a case with Prader-Willi syndrome (Gau et al, 1996), an unidentified disease with mental retardation and bilateral pyramidal syndrome (Livrea et al, 1977), another complex case of consanguinity, mental retardation, an ectodermal disorder (incontinentia pigmenti), acanthosis nigricans, and hereditary exostosis (Reimao and Shimizu, 1998) and developmental Asperger's disease in two patients, one with cortical dysplasia and retinitis pigmentosa (Berthier et al, 1992). As for the three patients with infectious encephalitis of unknown origin, one had an acute viral meningo-encephalitis and high CSF lymphocyte counts (Merriam, 1986) while another had a meningo-encephalitis with neurological sequels, including left hypo-sensitivity, central facial palsy, concentric loss of visual fields and bilateral facial spasms (Persson et al, 1969). KLS also occurred in a context of gastrointestinal symptoms in the 1930's in a woman with recurrent episodes of variable hypersomnia, sometimes severe insomnia, and diarrhoea lasting over a 30-year period (Wilder, 1972).…”
Section: Cases With Secondary Kls Causesmentioning
confidence: 99%
“…This hypothesis was scrutinized but could not be confirmed (9). Various exogenous factors can precipitate an attack such as fever and infections (10–12). Structural changes on computed tomography (CT) scan have been demonstrated in two patients who had hypodense lesions in the suprasellar cistern suggesting an infundibular lipoma (14).…”
mentioning
confidence: 99%
“…Its structure differs from that of orciprenaline by having a tertiary butyl ! :,'TOUp on the nitrogen atom instead of an isopropyl group and further from isoprenaline by having the OHg.roups of the benzene ring in the m zta position (Persson and Olsson, 1970).…”
Section: The Trialmentioning
confidence: 99%
“…Recently a new beta-receptor stimulating compound, terbutaline, has been synthesized and was first reported on by Bergman et al (1969). It is a derivative of resorcinol with the formula those of orciprenaline (Persson and Olsson, 1970). Preliminary Swedish clinical trials on patients with bronchial asthma have shown that terbutaline has a significant broncholytic effect when given both by mouth and subcutaneously (Arner et al, 1970;Arner, 1970;Formgren, 1970).…”
mentioning
confidence: 99%